157 related articles for article (PubMed ID: 24989928)
1. Association between the CYP3A4 and CYP3A5 polymorphisms and cancer risk: a meta-analysis and meta-regression.
He XF; Liu ZZ; Xie JJ; Wang W; Du YP; Chen Y; Wei W
Tumour Biol; 2014 Oct; 35(10):9859-77. PubMed ID: 24989928
[TBL] [Abstract][Full Text] [Related]
2. Association of
Liang Y; Han W; Yan H; Mao Q
J Cancer Res Ther; 2018 Jun; 14(Supplement):S463-S467. PubMed ID: 29970707
[TBL] [Abstract][Full Text] [Related]
3. Genetic association in
Bellah SF; Salam MA; Billah SMS; Karim MR
Ann Hum Biol; 2023 Feb; 50(1):63-74. PubMed ID: 36688864
[TBL] [Abstract][Full Text] [Related]
4. CYP3A4*1B Polymorphism and Cancer Risk: A Meta-Analysis Based on 55 Case-control Studies.
Zheng Y; Xu Y; Zhou BY; Sun L; Yu PB; Zhang L; Xu J; Wang JJ
Ann Clin Lab Sci; 2018 Jul; 48(4):538-545. PubMed ID: 30143500
[TBL] [Abstract][Full Text] [Related]
5. Association of CYP3A4, CYP3A5 polymorphisms with lung cancer risk in Bangladeshi population.
Islam MS; Mostofa AG; Ahmed MU; Bin Sayeed MS; Hassan MR; Hasnat A
Tumour Biol; 2014 Feb; 35(2):1671-8. PubMed ID: 24085358
[TBL] [Abstract][Full Text] [Related]
6. CYP3A4 and CYP3A5 genotypes, haplotypes, and risk of prostate cancer.
Plummer SJ; Conti DV; Paris PL; Curran AP; Casey G; Witte JS
Cancer Epidemiol Biomarkers Prev; 2003 Sep; 12(9):928-32. PubMed ID: 14504207
[TBL] [Abstract][Full Text] [Related]
7. CYP3A5*3 polymorphism and cancer risk: a meta-analysis and meta-regression.
Wang BS; Liu Z; Xu WX; Sun SL
Tumour Biol; 2013 Aug; 34(4):2357-66. PubMed ID: 23584898
[TBL] [Abstract][Full Text] [Related]
8. Association between cytochrome CYP17A1, CYP3A4, and CYP3A43 polymorphisms and prostate cancer risk and aggressiveness in a Korean study population.
Han JH; Lee YS; Kim HJ; Lee SY; Myung SC
Asian J Androl; 2015; 17(2):285-91. PubMed ID: 25337833
[TBL] [Abstract][Full Text] [Related]
9. CYP3A4*1B polymorphism and cancer risk: a HuGE review and meta-analysis.
Zhou LP; Yao F; Luan H; Wang YL; Dong XH; Zhou WW; Wang QH
Tumour Biol; 2013 Apr; 34(2):649-60. PubMed ID: 23179402
[TBL] [Abstract][Full Text] [Related]
10. Association between the CYP2E1 polymorphisms and lung cancer risk: a meta-analysis.
Ye XH; Song L; Peng L; Bu Z; Yan SX; Feng J; Zhu XL; Liao XB; Yu XL; Yan D
Mol Genet Genomics; 2015 Apr; 290(2):545-58. PubMed ID: 25336053
[TBL] [Abstract][Full Text] [Related]
11. The association among cytochrome P450 3A, progesterone receptor polymorphisms, plasma 17-alpha hydroxyprogesterone caproate concentrations, and spontaneous preterm birth.
Bustos ML; Caritis SN; Jablonski KA; Reddy UM; Sorokin Y; Manuck T; Varner MW; Wapner RJ; Iams JD; Carpenter MW; Peaceman AM; Mercer BM; Sciscione A; Rouse DJ; Ramin SM;
Am J Obstet Gynecol; 2017 Sep; 217(3):369.e1-369.e9. PubMed ID: 28522317
[TBL] [Abstract][Full Text] [Related]
12. CYP3A5 ∗ 3 genetic polymorphism is associated with childhood acute lymphoblastic leukemia risk: A meta-analysis.
Ma LM; Liu HC; Ruan LH; Feng YM
Biomed J; 2015; 38(5):428-32. PubMed ID: 25673168
[TBL] [Abstract][Full Text] [Related]
13. Association between the STK15 polymorphisms and risk of cancer: a meta-analysis.
Qin J; He XF; Wei W; Liu ZZ; Xie JJ; Wang W; Du YP; Chen Y; Si HQ
Mol Genet Genomics; 2015 Feb; 290(1):97-114. PubMed ID: 25154511
[TBL] [Abstract][Full Text] [Related]
14. Polymorphisms in CYP1B1, CYP3A5, GSTT1, and SULT1A1 Are Associated with Early Age Acute Leukemia.
Lopes BA; Emerenciano M; Gonçalves BA; Vieira TM; Rossini A; Pombo-de-Oliveira MS
PLoS One; 2015; 10(5):e0127308. PubMed ID: 25992585
[TBL] [Abstract][Full Text] [Related]
15. Association Between the CYP1B1 Polymorphisms and Lung Cancer Risk: A Meta-Analysis.
Chen PF; He XF; Huang GH; Wang W; Qiu ZH
Technol Cancer Res Treat; 2016 Oct; 15(5):NP73-82. PubMed ID: 26283052
[TBL] [Abstract][Full Text] [Related]
16. Association of CYP3A4*1G and CYP3A5*3 With the 1-year Outcome of Acute Ischemic Stroke in the Han Chinese Population.
Li S; Shi CH; Liu XJ; Li YS; Li SH; Song B; Xu YM
J Stroke Cerebrovasc Dis; 2019 Jul; 28(7):1860-1865. PubMed ID: 31064695
[TBL] [Abstract][Full Text] [Related]
17. Effect of CYP3A and ABCB1 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of calcineurin inhibitors: Part I.
Staatz CE; Goodman LK; Tett SE
Clin Pharmacokinet; 2010 Mar; 49(3):141-75. PubMed ID: 20170205
[TBL] [Abstract][Full Text] [Related]
18. Association between APE1 T1349G polymorphism and prostate cancer risk: evidence from a meta-analysis.
Li X; Zhang G; Huai YJ; Cao ZQ
Tumour Biol; 2014 Oct; 35(10):10111-9. PubMed ID: 25023401
[TBL] [Abstract][Full Text] [Related]
19. XPD Asp312Asn polymorphism is a risk factor for prostate cancer.
Liao SG; Liu L; Wang Y; Zhang YY; Wang YJ
J Cancer Res Clin Oncol; 2012 Oct; 138(10):1689-95. PubMed ID: 22644997
[TBL] [Abstract][Full Text] [Related]
20. Association between the CYP1A2 polymorphisms and risk of cancer: a meta-analysis.
Sun WX; Chen YH; Liu ZZ; Xie JJ; Wang W; Du YP; Chen Y; Shen XL; He XF; Wu LX; Wei W; Zhang L
Mol Genet Genomics; 2015 Apr; 290(2):709-25. PubMed ID: 25472037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
